Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (201-210 of 397) with videos related to

Pageof 40
Sort By:
Health Technology Assessment (Winchester, England)|December 8, 2025
Optimal provision of opiate substitution therapy and needle and syringe programmes: a multi-method realist evaluationPeter McCulloch, April Shaw, Gail Gilchrist, et al.
Journal of Viral Hepatitis|October 12, 2019
Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysisLucy Platt, Clare E French, Catherine R McGowan, et al.
Journal of the International AIDS Society|September 10, 2016
Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling studyKate M Mitchell, Holly J Prudden, Reynold Washington, et al.
The International Journal on Drug Policy|September 17, 2025
Differential risk for Hepatitis C and HIV among people who inject drugs in Kenya: a latent class analysis signaling needs for innovation in service deliveryHannah N Manley, Lindsey R Riback, Chenshu Zhang, et al.
Journal of the International AIDS Society|March 15, 2018
The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South AfricaMatthew Quaife, Fern Terris-Prestholt, Robyn Eakle, et al.
The Lancet. HIV|July 24, 2018
Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling studyJavier A Cepeda, Ksenia Eritsyan, Peter Vickerman, et al.
Sexually Transmitted Infections|December 17, 2013
Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina FasoAndrea J Low, Issouf Konate, Nicolas Nagot, et al.
BMC Infectious Diseases|July 10, 2023
Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling studyAdam Trickey, Sandra Bivegete, Erika Duffell, et al.
Hepatology (Baltimore, Md.)|June 9, 2021
Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in PrisonsAaron G Lim, Jack Stone, Behzad Hajarizadeh, et al.
The International Journal on Drug Policy|April 28, 2026
Modelling the impact of cuts in US PEPFAR funding for opioid agonist therapy and needle and syringe programmes on drug-related deaths and HIV and hepatitis C transmission among people who inject drugsKennedy Kipkoech Mutai, Carlo Delfin S Estadilla, Adelina Artenie, et al.
Pageof 40

Showing results (201-210 of 397) with videos related to

Sort By:
Pageof 40
Health Technology Assessment (Winchester, England)|December 8, 2025
Optimal provision of opiate substitution therapy and needle and syringe programmes: a multi-method realist evaluationPeter McCulloch, April Shaw, Gail Gilchrist, et al.
Journal of Viral Hepatitis|October 12, 2019
Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysisLucy Platt, Clare E French, Catherine R McGowan, et al.
Journal of the International AIDS Society|September 10, 2016
Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling studyKate M Mitchell, Holly J Prudden, Reynold Washington, et al.
The International Journal on Drug Policy|September 17, 2025
Differential risk for Hepatitis C and HIV among people who inject drugs in Kenya: a latent class analysis signaling needs for innovation in service deliveryHannah N Manley, Lindsey R Riback, Chenshu Zhang, et al.
Journal of the International AIDS Society|March 15, 2018
The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South AfricaMatthew Quaife, Fern Terris-Prestholt, Robyn Eakle, et al.
The Lancet. HIV|July 24, 2018
Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling studyJavier A Cepeda, Ksenia Eritsyan, Peter Vickerman, et al.
Sexually Transmitted Infections|December 17, 2013
Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina FasoAndrea J Low, Issouf Konate, Nicolas Nagot, et al.
BMC Infectious Diseases|July 10, 2023
Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling studyAdam Trickey, Sandra Bivegete, Erika Duffell, et al.
Hepatology (Baltimore, Md.)|June 9, 2021
Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in PrisonsAaron G Lim, Jack Stone, Behzad Hajarizadeh, et al.
The International Journal on Drug Policy|April 28, 2026
Modelling the impact of cuts in US PEPFAR funding for opioid agonist therapy and needle and syringe programmes on drug-related deaths and HIV and hepatitis C transmission among people who inject drugsKennedy Kipkoech Mutai, Carlo Delfin S Estadilla, Adelina Artenie, et al.
Pageof 40